- Book
- January 2017
- 488 Pages
- Book
- January 2016
- 952 Pages
- Book
- April 2009
- 584 Pages
- Book
- May 2025
North America
- Book
- August 2023
North America
- Book
- June 2020
North America
Thromboembolism is a medical condition in which a blood clot forms in a vein or artery, blocking the flow of blood. It is a serious condition that can lead to stroke, heart attack, and other life-threatening complications. Healthcare services play an important role in the prevention, diagnosis, and treatment of thromboembolism. Diagnostic tests such as Doppler ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI) are used to detect the presence of a clot. Treatment options include anticoagulant medications, thrombolytic therapy, and surgical interventions.
Companies in the thromboembolism market include Boehringer Ingelheim, Pfizer, Sanofi, Bayer, and Bristol-Myers Squibb. These companies offer a range of products and services, including anticoagulant medications, thrombolytic agents, and diagnostic tests. Show Less Read more